Reversible alopecia after single-dose methotrexate treatment in a patient with ectopic pregnancy.
To report a case of a women who received a single 50 mg/m2 dose of methotrexate (MTX) on two occasions for two separate ectopic pregnancies. After both treatments the patient experienced reversible alopecia. Case report. Single human patient in a university-run clinic. A patient with an ectopic pregnancy presenting for treatment on two separate occasions. A single dose of 50 mg/m2 MTX given to the patient on both occasions. Loss of scalp hair. On two separate occasions the patient lost a significant portion (33% to 50%) of her scalp hair. Even single-dose MTX as used for the treatment of ectopic pregnancy may induce alopecia in a susceptible patient.